Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (76)

2023

  1. A Clustered Schedule for Venom Immunotherapy With a Depot Extract: Reaching the Target in 7 Days

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 5, pp. 395-397

  2. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  3. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  4. Immunotherapy for asthma

    The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 249-263

  5. Proteomics of Vespa velutina nigrithorax Venom Sac Queens and Workers: A Quantitative SWATH-MS Analysis

    Toxins, Vol. 15, Núm. 4

  6. Prueba de activación de basófilos en el seguimiento de pacientes que reciben inmunoterapia con veneno de himenópteros: revisión de la evidencia actual

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), Vol. 69, Núm. 3, pp. 125-137

  7. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

  8. Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study

    Patient Preference and Adherence, Vol. 17, pp. 1771-1782

2021

  1. Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 629-647

2020

  1. Limited diagnostic value of total serum IgG4 measurements in adult patients

    Annals of Allergy, Asthma and Immunology, Vol. 124, Núm. 2, pp. 202-203